|
MicroDose
considers strong and broad Intellectual Property protection to be a key strategy
for sustaining competitive advantage. All of MicroDose’s core technologies are
supported by issued US and international patents and pending patent applications.
MicroDose performs all of its own core R&D and as such all of its core technologies
have been developed internally and are wholly owned by MicroDose. MicroDose,
in turn, makes their intellectual property available to partners under appropriate
licensing agreements.
MicroDose’s current intellectual property portfolio consists of the following:
13 US issued patents
12 US patent applications pending
10 International issued patents
44 International patents pending on a regional or specific country basis
3 Trademarks registered and pending in the US and internationally
|
|